Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

Preparation and use of new lactams as inhibitors of serine proteases, antibiotics

July 26, 2000

Imperial College Innovations launches company for allergy therapies

July 26, 2000

Chemokine CCR3 receptor modulators claimed by DuPont in recent patent literature

July 25, 2000

BCY Ventures selects lead compound for CF therapy

July 25, 2000

Inhaled furosemide reduces experimental dyspnea in humans

July 25, 2000

Zambon and Sheffield submit IND for MSI-cromolyn

July 21, 2000

K-5993: a new peptide IL-4 antagonist

July 20, 2000

Triazolo CCR3 receptor antagonists claimed by Toray for Rx of allergic diseases, etc.

July 20, 2000

Purines 2000: a potent and selective A2B antagonist effective in asthma, retinopathy

July 19, 2000

Sankyo claims potent tachykinin antagonist series

July 18, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 16, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
EHA 2026: With new lenses, a changing view on pediatric cancers
BioWorld
In the most simplistic view, adult cancers occur because “immature cells are exposed to mutagens, accumulate mutations, and across life ultimately transform into...
Anti-C5aR1 antibodies linked to outcomes in giant cell arteritis
BioWorld Science
More effective glucocorticoid-sparing therapies are needed for the treatment of giant cell arteritis (GCA). Studies found that complement signaling pathways...
Fortvita and Innovent patent new anti-TROP2/B7-H4 ADCs
BioWorld Science
Fortvita Biologics Inc. and Innovent Biologics (Suzhou) Co. Ltd. have jointly reported new antibody-drug conjugates (ADCs) comprising a bispecific antibody or...